Journal of Medicinal Chemistry · 2011 · 44 citations · 24 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructural BiologyLigand BindingMolecular DockingProtein DockingProtein-ligand DockingDocking-based Drug DesignHomologyMolecular Docking Of InhibitorsStructure-based Lead DiscoveryStructure-based Ligand DesignTarget Protein Structure
The lack of substrate-bound crystal structures of SIRT1 and SIRT2 complicates the drug design for these targets. In this work, we aim to study whether SIRT3 could serve as a target structure in the design of substrate based pseudopeptidic inhibitors of SIRT1 and SIRT2. We created a binding hypothesis for pseudopeptidic inhibitors, synthesized a series of inhibitors, and studied how well the fulfillment of the binding criteria proposed by the hypothesis correlated with the in vitro inhibitory activities. The chosen approach was further validated by studying docking results between 12 different SIRT3, Sir2Tm, SIRT1 and SIRT2 X-ray structures and homology models in different conformational forms. It was concluded that the created binding hypothesis can be used in the design of the substrate based inhibitors of SIRT1 and SIRT2 although there are some reservations, and it is better to use the substrate-bound structure of SIRT3 instead of the available apo-SIRT2 as the target structure.
24
Clustal W and Clustal X version 2.0
Mark Larkin, Gordon Blackshields, Nigel P. Brown et al. · Bioinformatics · 2007 · 29.1K citations · Full text
Jalview Version 2—a multiple sequence alignment editor and analysis workbench
Andrew Waterhouse, James B Procter, David Martin et al. · Bioinformatics · 2009 · 10.9K citations · Full text
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Jill C. Milne, Philip Lambert, Simon Schenk et al. · Nature · 2007 · 1.7K citations · Full text
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Research · 2009 · 1.3K citations · Full text